Live feed19:42:06·58dINSIDERFilingChief Financial Officer Piekos Brian converted options into 5,000 shares and sold $27,507 worth of shares (1,767 units at $15.57), increasing direct ownership by 31% to 13,762 units (SEC Form 4)KALV· KalVista Pharmaceuticals Inc.Health CareOriginal source